Shanghai Model Organisms Center Inc (688265) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Model Organisms Center Inc (688265) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.97 Million ≈ $2.34 Million USD) by net assets (CN¥1.70 Billion ≈ $249.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Model Organisms Center Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Shanghai Model Organisms Center Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Model Organisms Center Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Shanghai Model Organisms Center Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Model Organisms Center Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
SHE:002864
|
0.016x |
|
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SHG:603976
|
0.039x |
|
Qingdao Richmat Intelligence Technology Co. Ltd. A
SHE:301320
|
N/A |
|
Temple & Webster Group Ltd
AU:TPW
|
0.227x |
|
Manitowoc Company Inc
NYSE:MTW
|
-0.021x |
|
Zhongtong Guomai Communication
SHG:603559
|
-0.131x |
|
Valneva SE
PA:VLA
|
-0.116x |
|
Daesang Corp
KO:001680
|
0.093x |
Annual Cash Flow Conversion Efficiency for Shanghai Model Organisms Center Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Model Organisms Center Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Shanghai Model Organisms Center Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.68 Billion ≈ $246.28 Million |
CN¥71.56 Million ≈ $10.47 Million |
0.043x | +267.74% |
| 2023-12-31 | CN¥1.74 Billion ≈ $254.15 Million |
CN¥20.08 Million ≈ $2.94 Million |
0.012x | +8.08% |
| 2022-12-31 | CN¥1.77 Billion ≈ $258.41 Million |
CN¥18.89 Million ≈ $2.76 Million |
0.011x | -82.88% |
| 2021-12-31 | CN¥1.78 Billion ≈ $261.01 Million |
CN¥111.46 Million ≈ $16.31 Million |
0.062x | -73.05% |
| 2020-12-31 | CN¥254.93 Million ≈ $37.30 Million |
CN¥59.10 Million ≈ $8.65 Million |
0.232x | -9.74% |
| 2019-12-31 | CN¥135.38 Million ≈ $19.81 Million |
CN¥34.77 Million ≈ $5.09 Million |
0.257x | +145.19% |
| 2018-12-31 | CN¥112.13 Million ≈ $16.41 Million |
CN¥11.75 Million ≈ $1.72 Million |
0.105x | +23.43% |
| 2017-12-31 | CN¥97.02 Million ≈ $14.20 Million |
CN¥8.23 Million ≈ $1.20 Million |
0.085x | -67.69% |
| 2016-12-31 | CN¥98.35 Million ≈ $14.39 Million |
CN¥25.83 Million ≈ $3.78 Million |
0.263x | -20.05% |
| 2015-12-31 | CN¥62.18 Million ≈ $9.10 Million |
CN¥20.43 Million ≈ $2.99 Million |
0.329x | -- |
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, a… Read more